Ann Dermatol.  2018 Oct;30(5):562-565. 10.5021/ad.2018.30.5.562.

Identification of Mycobacterium leprae and Mycobacterium lepromatosis in Formalin-Fixed and Paraffin-Embedded Skin Samples from Mexico

Affiliations
  • 1Mycology Service, Dermatological Center of Yucatan Dr. Fernando Latapi, Yucatan 97000, Mexico.
  • 2Mycology Service, General Hospital Dr. Manuel Gea Gonzalez, Mexico City 14080, Mexico.
  • 3Department of Molecular Biology and Histocompatibility, General Hospital Dr. Manuel Gea Gonzalez, Mexico City 14080, Mexico.
  • 4Intestinal Bacteriology Laboratory, Childrens Hospital of Mexico Dr. Federico Gomez, Mexico City 06720, Mexico.
  • 5Department of Ecology of Pathogen Agents, General Hospital Dr. Manuel Gea Gonzalez, Mexico City 14080, Mexico. rhc@unam.mx

Abstract

BACKGROUND
The causative agents of leprosy are the well-known Mycobacterium leprae and the newly discovered Mycobacterium lepromatosis. This agent was found in 2008, and it was found to be the cause of diffuse lepromatous leprosy in two Mexican patients.
OBJECTIVE
The objective of this work was to determine if M. leprae and M. lepromatosis were present in formalin-fixed and paraffin-embedded skin samples from cases from different regions in Mexico.
METHODS
A total of 41 skin samples were obtained from 11 states of Mexico. All patients' samples were diagnosed by clinical and histopathological analyses. Total DNA was isolated using a Qiagen-DNeasy blood and tissue kit and molecular identification was achieved by two semi-nested polymerase chain reactions.
RESULTS
The 41 patient included 33 samples from men and 8 samples from women; 29 samples were polymerase chain reaction (PCR)-positive to Mycobacterium and 12 samples were PCR-negative. From those 29 samples, 13 were PCR-positive to M. leprae, 8 to M. lepromatosis and 8 were positive to both species. The histopathological diagnosis included; Nodular lepromatous leprosy (NLL); Diffuse lepromatous leprosy (DLL); and Borderline leprosy (BL). The 29 PCR-positive samples were classified as follow: 14 NLL, 4 DLL, and 11 BL. In the 12 samples negative to Mycobacterium, 7 showed the NLL, 2 DLL and 3 BL.
CONCLUSION
These findings add evidence to the M. leprae and M. lepromatous distribution, clinical forms and participation of dual infections in Mexico.

Keyword

Diffuse lepromatous leprosy; Leprosy; Mycobacterium leprae; Mycobacterium lepromatosis; Nodular lepromatous leprosy

MeSH Terms

Diagnosis
DNA
Female
Hospital Distribution Systems
Humans
Leprosy
Leprosy, Borderline
Leprosy, Lepromatous
Male
Mexico*
Mycobacterium leprae*
Mycobacterium*
Polymerase Chain Reaction
Skin*
DNA

Reference

1. Lupi O, Madkan V, Tyring SK. Tropical dermatology: bacterial tropical diseases. J Am Acad Dermatol. 2006; 54:559–578. PMID: 16546577.
Article
2. Han XY, Seo YH, Sizer KC, Schoberle T, May GS, Spencer JS, et al. A new mycobacterium species causing diffuse lepromatous leprosy. Am J Clin Pathol. 2008; 130:856–864. PMID: 19019760.
3. World Health Organization. Global leprosy update, 2015: time for action, accountability and inclusion. Wkly Epidemiol Rec. 2016; 91:405–420.
4. Secretaria de la Salud. Dirección General de Epidemiología [Internet]. Mexico City: GOB.MX;2016. updated 2016 Mar 7. cited 2018 Apr 3. Available from: https://www.gob.mx/salud/acciones-y-programas/direccion-general-deepidemiologia.
5. Han XY, Sizer KC, Thompson EJ, Kabanja J, Li J, Hu P, et al. Comparative sequence analysis of mycobacterium leprae and the new leprosy-causing mycobacterium lepromatosis. J Bacteriol. 2009; 191:6067–6074. PMID: 19633074.
6. Han XY, Sizer KC, Velarde-Félix JS, Frias-Castro LO, Vargas-Ocampo F. The leprosy agents mycobacterium lepromatosis and mycobacterium leprae in Mexico. Int J Dermatol. 2012; 51:952–959. PMID: 22788812.
Article
7. Han XY, Mistry NA, Thompson EJ, Tang HL, Khanna K, Zhang L. Draft genome sequence of new leprosy agent mycobacterium lepromatosis. Genome Announc. 2015; 3:e00513–e00515. PMID: 25999555.
Article
8. Singh P, Benjak A, Schuenemann VJ, Herbig A, Avanzi C, Busso P, et al. Insight into the evolution and origin of leprosy bacilli from the genome sequence of mycobacterium lepromatosis. Proc Natl Acad Sci U S A. 2015; 112:4459–4464. PMID: 25831531.
Article
9. Cox RA, Kempsell K, Fairclough L, Colston MJ. The 16S ribosomal RNA of mycobacterium leprae contains a unique sequence which can be used for identification by the polymerase chain reaction. J Med Microbiol. 1991; 35:284–290. PMID: 1719203.
10. Pfaltzgraff RE. What is the actual male/female sex ratio in leprosy patients? Lepr Rev. 2003; 74:180–181. PMID: 12862262.
11. Atoche C, Torres-Guerrero E, Vargas F, Arenas R. [Leprosy in Yucatan, retrospective clinical study of 63 years (1950–2013)]. Salud Publica Mex. 2015; 57:191–192. Spanish. PMID: 26302115.
12. Han XY, Aung FM, Choon SE, Werner B. Analysis of the leprosy agents mycobacterium leprae and mycobacterium lepromatosis in four countries. Am J Clin Pathol. 2014; 142:524–532. PMID: 25239420.
Article
13. Vera-Cabrera L, Escalante-Fuentes WG, Gomez-Flores M, Ocampo-Candiani J, Busso P, Singh P, et al. Case of diffuse lepromatous leprosy associated with “mycobacterium lepromatosis”. J Clin Microbiol. 2011; 49:4366–4368. PMID: 22012006.
Article
14. Vera-Cabrera L, Escalante-Fuentes W, Ocampo-Garza SS, Ocampo-Candiani J, Molina-Torres CA, Avanzi C, et al. Mycobacterium lepromatosis infections in Nuevo León, Mexico. J Clin Microbiol. 2015; 53:1945–1946. PMID: 25809978.
Article
15. Han XY, Sizer KC, Tan HH. Identification of the leprosy agent mycobacterium lepromatosis in Singapore. J Drugs Dermatol. 2012; 11:168–172. PMID: 22270197.
16. Jessamine PG, Desjardins M, Gillis T, Scollard D, Jamieson F, Broukhanski G, et al. Leprosy-like illness in a patient with mycobacterium lepromatosis from Ontario, Canada. J Drugs Dermatol. 2012; 11:229–233. PMID: 22270208.
17. Han XY. Detection of the leprosy agent mycobacterium lepromatosis in South America and Europe. Am J Trop Med Hyg. 2017; 96:260. PMID: 27879462.
18. Sotiriou MC, Stryjewska BM, Hill C. Two cases of leprosy in siblings caused by mycobacterium lepromatosis and review of the literature. Am J Trop Med Hyg. 2016; 95:522–527. PMID: 27402522.
Article
19. Virk A, Pritt B, Patel R, Uhl JR, Bezalel SA, Gibson LE, et al. Mycobacterium lepromatosis lepromatous leprosy in US citizen who traveled to disease-endemic areas. Emerg Infect Dis. 2017; 23:1864–1866. PMID: 29048278.
20. Gillis TP, Scollard DM, Lockwood DN. What is the evidence that the putative mycobacterium lepromatosis species causes diffuse lepromatous leprosy? Lepr Rev. 2011; 82:205–209. PMID: 22125927.
Article
21. Herath S, Navinan MR, Liyanage I, Rathnayaka N, Yudhishdran J, Fernando J, et al. Lucio's phenomenon, an uncommon occurrence among leprosy patients in Sri Lanka. BMC Res Notes. 2015; 8:672. PMID: 26566619.
Article
Full Text Links
  • AD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr